| Date Filed | Type | Description |
| 01/19/2022 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I... |
| 01/10/2022 |
SC 13G/A
| STATE STREET CORP reports a 5.2% stake in AMENDED FILING SERES THERAPEUTICS INC |
| 01/10/2022 |
SC 13G/A
| STATE STREET CORP reports a 1.5% stake in EXIT FILING HUMANIGEN INC |
| 01/10/2022 |
SC 13G/A
| STATE STREET CORP reports a 2.9% stake in EXIT FILING SPECTRUM PHARMACEUTICALS INC |
| 01/10/2022 |
SC 13G
| STATE STREET CORP reports a 10.1% stake in INITIAL FILING 2SEVENTY BIO INC |
| 01/10/2022 |
SC 13G
| STATE STREET CORP reports a 11.1% stake in INITIAL FILING DECIPHERA PHARMACEUTICALS INC |
| 01/10/2022 |
SC 13G
| STATE STREET CORP reports a 10.2% stake in INITIAL FILING URANIUM ENERGY CORP |
| 01/10/2022 |
SC 13G
| STATE STREET CORP reports a 10.9% stake in INITIAL FILING BLUEBIRD BIO INC |
| 12/21/2021 |
4
| Hu W. Bradford (Executive Vice President) has filed a Form 4 on STATE STREET CORP|
Txns:
| Granted 5,889 shares
@ $0 |
|
| 12/13/2021 |
4
| Taraporevala Cyrus (EVP; President and CEO of SSGA) has filed a Form 4 on STATE STREET CORP|
Txns:
| Sold 4,487 shares
@ $92.12, valued at
$413.3k
|
|
| 12/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/18/2021 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 11/17/2021 |
4
| O HANLEY RONALD P (Chairman, President and CEO) has filed a Form 4 on STATE STREET CORP|
Txns:
| Gifted 10,475 shares
@ $0
Disposed/sold 7,743 shares
@ $99.92, valued at
$773.7k
Exercised 7,743 options to buy
@ $0 |
|
| 11/17/2021 |
4
| RICHARDS MICHAEL L (EVP and Chief Admin Officer) has filed a Form 4 on STATE STREET CORP|
Txns:
| Paid exercise price by delivering 476 shares
@ $99.92, valued at
$47.6k
Sold 262 shares
@ $99.58, valued at
$26.1k
|
|
| 11/17/2021 |
4
| PHELAN DAVID C (EVP; Gen Counsel and Secretary) has filed a Form 4 on STATE STREET CORP|
Txns:
| Paid exercise price by delivering 1,059 shares
@ $99.92, valued at
$105.8k
|
|
| 11/17/2021 |
4
| Aristeguieta Francisco (EVP and CEO of Inst. Services) has filed a Form 4 on STATE STREET CORP|
Txns:
| Sold 22,200 shares
@ $99.45, valued at
$2.2M
|
|
| 11/17/2021 |
3
| Hu W. Bradford (Executive Vice President) has filed a Form 3 on STATE STREET CORP |
| 11/16/2021 |
424B2
| Form 424B2 - Prospectus [Rule 424(b)(2)]: |
| 11/16/2021 |
4
| de Saint-Aignan Patrick (Director) has filed a Form 4 on STATE STREET CORP|
Txns:
| Sold 1,000 shares
@ $99.12, valued at
$99.1k
|
|
| 11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/15/2021 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 11/12/2021 |
4
| de Saint-Aignan Patrick (Director) has filed a Form 4 on STATE STREET CORP|
Txns:
| Sold 3,000 shares
@ $96.66, valued at
$290k
Sold 2,000 shares
@ $97.75, valued at
$195.5k
|
|
| 11/10/2021 |
4
| Taraporevala Cyrus (EVP; President and CEO of SSGA) has filed a Form 4 on STATE STREET CORP|
Txns:
| Sold 4,487 shares
@ $95.74, valued at
$429.6k
|
|
| 11/09/2021 |
SC 13G/A
| STATE STREET CORP reports a 12.7% stake in AMENDED FILING SOUTH JERSEY INDUSTRIES INC |
| 10/22/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 10/18/2021 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I... |
| 10/12/2021 |
4
| Taraporevala Cyrus (EVP; President and CEO of SSGA) has filed a Form 4 on STATE STREET CORP|
Txns:
| Sold 4,487 shares
@ $89.23, valued at
$400.4k
|
|
| 10/12/2021 |
SC 13G/A
| STATE STREET CORP reports a 1.6% stake in EXIT FILING ATHENEX INC |
| 10/12/2021 |
SC 13G
| STATE STREET CORP reports a 10.9% stake in INITIAL FILING SERES THERAPEUTICS INC |
| 10/12/2021 |
SC 13G/A
| STATE STREET CORP reports a 2.1% stake in EXIT FILING ADVERUM BIOTECHNOLOGIES INC |
| 10/12/2021 |
SC 13G/A
| STATE STREET CORP reports a 10.4% stake in AMENDED FILING G1 THERAPEUTICS INC |
| 10/12/2021 |
SC 13G/A
| STATE STREET CORP reports a 10.6% stake in AMENDED FILING KARYOPHARM THERAPEUTICS INC |
| 10/12/2021 |
SC 13G
| STATE STREET CORP reports a 14.8% stake in INITIAL FILING HUMANIGEN INC |
|